Donald Tecca
Internal Medicine · San Diego, CANPI 1235163163
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 351 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,802 and has fallen 99.1% since, to $16 in 2025. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 351 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$863
- GSK$763
- Amgen$486
- Novo Nordisk$422
- Pfizer$236
- plus $3K from 35 others
What the payments were for
- Food & beverage$6,555100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 64 | $1,216 |
| AstraZeneca | 42 | $863 |
| GSK | 36 | $763 |
| Amgen | 26 | $486 |
| Novo Nordisk | 20 | $422 |
| Pfizer | 13 | $236 |
| Teva Pharmaceuticals USA, Inc. | 9 | $217 |
| Lilly USA, LLC | 12 | $212 |
| Novartis | 12 | $191 |
| Boston Scientific | 11 | $181 |
| Johnson & Johnson | 12 | $170 |
| Antares Pharma, Inc. | 8 | $140 |
| Merck | 8 | $138 |
| Astellas Pharma US Inc | 8 | $121 |
| Biohaven Pharmaceuticals, Inc. | 6 | $112 |
| Tactile Systems Technology Inc | 8 | $110 |
| Neurocrine Biosciences, Inc. | 6 | $102 |
| Radius Health, Inc. | 5 | $96 |
| Boehringer Ingelheim | 5 | $77 |
| Jazz Pharmaceuticals Inc. | 4 | $71 |
| Sanofi-aventis U.S. LLC | 5 | $70 |
| Atricure, Inc. | 1 | $59 |
| Gilead | 3 | $51 |
| E.r. Squibb & Sons, L.L.C. | 3 | $49 |
| Abbott | 2 | $44 |
| Bayer | 2 | $42 |
| Eisai Inc. | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Dermira, Inc. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Medtronic | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $24 |
| Zealand Pharma US, Inc. | 1 | $18 |
| Duchesnay USA Incorporated | 1 | $17 |
| CSL Behring | 1 | $17 |
| Linus Health, Inc. | 1 | $15 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Optos, Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Seqirus USA Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,555 in reported general payments places this provider in the 90th percentile of 13,581 internal medicine providers in California.
Other internal medicine in San Diego
- Hatim HusainSan Diego$2M
- Steven EdelmanSan Diego$863K
- Christian RamersSan Diego$675K
- Adam ZweigSan Diego$421K
- James BreitmeyerSan Diego$227K
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Teck LingPalo Alto$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.